Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Guardado en:
Detalles Bibliográficos
Autores principales: Martin Lauss, Marco Donia, Katja Harbst, Rikke Andersen, Shamik Mitra, Frida Rosengren, Maryem Salim, Johan Vallon-Christersson, Therese Törngren, Anders Kvist, Markus Ringnér, Inge Marie Svane, Göran Jönsson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/cf6ac8b989324b07a79b03ff14d6349c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cf6ac8b989324b07a79b03ff14d6349c
record_format dspace
spelling oai:doaj.org-article:cf6ac8b989324b07a79b03ff14d6349c2021-12-02T14:40:43ZAuthor Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma10.1038/s41467-020-15531-22041-1723https://doaj.org/article/cf6ac8b989324b07a79b03ff14d6349c2020-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-15531-2https://doaj.org/toc/2041-1723An amendment to this paper has been published and can be accessed via a link at the top of the paper.Martin LaussMarco DoniaKatja HarbstRikke AndersenShamik MitraFrida RosengrenMaryem SalimJohan Vallon-ChristerssonTherese TörngrenAnders KvistMarkus RingnérInge Marie SvaneGöran JönssonNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-1 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Martin Lauss
Marco Donia
Katja Harbst
Rikke Andersen
Shamik Mitra
Frida Rosengren
Maryem Salim
Johan Vallon-Christersson
Therese Törngren
Anders Kvist
Markus Ringnér
Inge Marie Svane
Göran Jönsson
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
description An amendment to this paper has been published and can be accessed via a link at the top of the paper.
format article
author Martin Lauss
Marco Donia
Katja Harbst
Rikke Andersen
Shamik Mitra
Frida Rosengren
Maryem Salim
Johan Vallon-Christersson
Therese Törngren
Anders Kvist
Markus Ringnér
Inge Marie Svane
Göran Jönsson
author_facet Martin Lauss
Marco Donia
Katja Harbst
Rikke Andersen
Shamik Mitra
Frida Rosengren
Maryem Salim
Johan Vallon-Christersson
Therese Törngren
Anders Kvist
Markus Ringnér
Inge Marie Svane
Göran Jönsson
author_sort Martin Lauss
title Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
title_short Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
title_full Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
title_fullStr Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
title_full_unstemmed Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
title_sort author correction: mutational and putative neoantigen load predict clinical benefit of adoptive t cell therapy in melanoma
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/cf6ac8b989324b07a79b03ff14d6349c
work_keys_str_mv AT martinlauss authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT marcodonia authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT katjaharbst authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT rikkeandersen authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT shamikmitra authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT fridarosengren authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT maryemsalim authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT johanvallonchristersson authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT theresetorngren authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT anderskvist authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT markusringner authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT ingemariesvane authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
AT goranjonsson authorcorrectionmutationalandputativeneoantigenloadpredictclinicalbenefitofadoptivetcelltherapyinmelanoma
_version_ 1718390201686949888

Ejemplares similares